Why the study?
Recent Western guidelines recommend non-fasting lipid profiles to manage dyslipidaemia, but their applicability to an Asian population needed exploration.
Does a non-fasting lipid profile provide comparable results to an overnight fasting lipid profile in Asian patients with T2DM and dyslipidemia?
Does a non-fasting lipid profile provide comparable results to an overnight fasting lipid profile in Asian patients with T2DM and dyslipidemia?
Non-fasting lipid profiles show good correlation with fasting profiles for total cholesterol, HDL-C, LDL-C, and non-HDL-C in Asian patients with T2DM on statins, supporting their use in clinical practice.
Non-fasting lipids may be acceptable for most parameters in Asian T2DM; leaves open prospective validation and triglyceride reliability.
Recent Western guidelines recommend non-fasting lipid profiles to manage dyslipidaemia. We explored its applicability to an Asian population. We determined the differences between an overnight fasting and non-fasting cholesterol profiles of patients with type-2 diabetes mellitus (T2DM) in Singapore. We studied 470 multi-ethnic Asian adult patients with T2DM and dyslipidaemia from 2 primary care clinics in Singapore. Non-fasting blood specimens were collected within 6 h after their last meal and within 14 days of a fasting specimen. The intraclass correlation coefficient (ICC) was used to compare the intraindividual lipid profiles. An ICC value > 0.75 implies good correlation. The mean age and T2DM duration of the study population were 62.5 years and 9.8 years respectively. Their mean non-fasting period was 2.46 h. The mean differences between non-fasting and fasting total cholesterol (TC), high-density lipoprotein (HDL-C), triglyceride (TG), low-density lipoprotein (LDL-C), and non HDL-C were + 0.04 mmol/l, - 0.001 mmol/l, + 0.48 mmol/l, - 0.15 mmol/l, and - 0.05 mmol/l respectively. The ICC (95% CI) for TC, HDL-C, TG, LDL-C and non-HDL-C were 0.820 (0.788-0.847), 0.873 (0.850-0.893), 0.579 (0.516-0.636), 0.764 (0.723-0.799), and 0.825 (0.794-0.852) respectively. The fasting and non-fasting lipid profiles were similar in our local Asian patients with T2DM taking statin. Their non-fasting lipid profile can be used to assess their cholesterol treatment status.
No takes yet. Share an insight, caveat, or question.
Phoon et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: